Immunohistochemistry (IHC) showed that the expression levels of Oct-4 in the lung tumors of LC-CD133+-injected SCID mice were highly expressed in comparison with the other treated-groups (Fig. 7C). The gene discussed is POU5F1; the disease is laryngotracheoesophageal cleft.